Eyepoint Pharmaceuticals Inc (EYPT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Eyepoint Pharmaceuticals Inc-Aktie (EYPT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	78.19% 5.333	24.45	11.59	10.52	9.477
Operating Expenses	7.82% 67.56	73.29	59.72	42.54	42.62
Benefits Costs and Expenses	7.15% 64.67	69.65	52.90	43.27	44.02
Costs And Expenses	7.15% 64.67	69.65	41.75	43.27	44.02
Depreciation and Amortization	8.25% 0.538	0.497	0.467	-	-
Operating Income/Loss	27.42% -62.23	-48.84	-45.24	-32.75	-34.55
Nonoperating Income/Loss	20.54% 2.894	3.642	3.93	3.387	3.72
Income/Loss From Continuing Operations Before Tax	31.28% -59.33	-45.20	-41.31	-32.75	-34.55
Income Tax Expense/Benefit	0.093	-	-	-	-
Income/Loss From Continuing Operations After Tax	31.49% -59.43	-45.20	-41.40	-29.36	-30.83
Net Income/Loss	31.49% -59.43	-45.20	-41.40	-29.36	-30.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.90% 0.0699	69.77	-53.47	54.45	53.21
Diluted Average Shares	99.90% 0.0699	69.77	-53.47	54.45	53.21
Basic Earnings Per Share	30.77% -0.85	-0.65	-0.65	-0.54	-0.58
Diluted Earnings Per Share	30.77% -0.85	-0.65	-0.65	-0.54	-0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$85.44

1.75%

GMAB

$27.38

1.11%

SMMT

$23.80

1.19%

BNTX

$103.50

3.07%

INSM

$142.53

0.68%

ONC

$318.73

5.21%